<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:java="http://xml.apache.org/xslt/java" xmlns:dt="http://xsltsl.org/date-time">
<channel>
<title>BlogPulse Search Results for: lopinavir ritonavir</title>
<link>http://www.blogpulse.com/rss?query=lopinavir+ritonavir</link>
<description>BlogPulse Search Results for: lopinavir ritonavir</description>
<pubDate>Tue, 09 Feb 2010 18:45:37 EST</pubDate>
<lastBuildDate>Tue, 09 Feb 2010 18:45:37 EST</lastBuildDate>
<generator>BlogPulse</generator>
<ttl>60</ttl>
<image>
<url>http://www.blogpulse.com/images/home_topnav3_logo.gif</url>
<title>BlogPulse Search Results for: lopinavir ritonavir</title>
<link>http://www.blogpulse.com/search?query=lopinavir+ritonavir</link>
<width>144</width>
<height>55</height>
</image>
<item>
<title>La Noticia del Día 04/02/2010: La Unión Europea aprueba el nuevo Norvir®</title>
<link>http://saludricotetoday.blogspot.com/2010/02/la-noticia-del-dia-04022010-la-union.html</link>
<description> ... y es la misma que hace unos años esta farmacéutica utilizó para crear los comprimidos de lopinavir/ritonavir (Kaletra®)...</description>
<pubDate>Thu, 04 Feb 2010 03:34:15 EDT</pubDate>
<source url="http://saludricotetoday.blogspot.com">-- Salud</source>
</item>
<item>
<title>Drug Trials - Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials</title>
<link>http://medhealthnews.blogspot.com/2010/02/drug-trials-switch-to-raltegravir-based.html</link>
<description>Sponsor                                                                                             </description>
<pubDate>Mon, 01 Feb 2010 10:28:59 EDT</pubDate>
<source url="http://medhealthnews.blogspot.com">med health news</source>
</item>
<item>
<title>Management of the Patient with Statin Intolerance</title>
<link>http://medhealthnews.blogspot.com/2010/02/management-of-patient-with-statin.html</link>
<description>Sponsor                                                                                             </description>
<pubDate>Mon, 01 Feb 2010 10:23:03 EDT</pubDate>
<source url="http://medhealthnews.blogspot.com">med health news</source>
</item>
<item>
<title>Antimicrobials - Polyphyletic Emergence of Linezolid-Resistant Staphylococci in the United States</title>
<link>http://medhealthnews.blogspot.com/2010/02/antimicrobials-polyphyletic-emergence.html</link>
<description>Sponsor                                                                                             </description>
<pubDate>Mon, 01 Feb 2010 10:22:28 EDT</pubDate>
<source url="http://medhealthnews.blogspot.com">med health news</source>
</item>
<item>
<title>HIV/AIDS Update - Kaletra (lopinavir/ritonavir) package insert revision regarding drug-drug interaction information</title>
<link>http://neurologist.wordpress.com/2010/01/30/hivaids-update-kaletra-lopinavirritonavir-package-insert-revision-regarding-drug-drug-interaction-information</link>
<description>On January 29, 2009, FDA approved revisions to the Kaletra (lopinavir/ritonavir)...</description>
<pubDate>Sat, 30 Jan 2010 13:10:05 EDT</pubDate>
<source url="http://neurologist.wordpress.com">Neurologist</source>
</item>
<item>
<title>Tratamiento Antirretroviral de Gran Actividad (TARGA).</title>
<link>http://www.papin.pe/index.php/2010/01/30/tratamiento-antirretroviral-de-gran-actividad-targa/</link>
<description>El componente VIH del Programa de la II Ronda del Fondo Mundial debía complementar y ampliar un</description>
<pubDate>Sat, 30 Jan 2010 07:56:47 EDT</pubDate>
<source url="http://www.papin.pe">Papin</source>
</item>
<item>
<title>HIV/AIDS Update - Kaletra (lopinavir/ritonavir) package insert revision regarding drug-drug interaction information</title>
<link>http://fda.bisina.info/2010/01/hivaids-update-kaletra.html</link>
<description>On January 29, 2009, FDA approved revisions to the Kaletra (lopinavir/ritonavir)...</description>
<pubDate>Fri, 29 Jan 2010 15:19:01 EDT</pubDate>
<source url="http://fda.bisina.info">Medicine and Health</source>
</item>
<item>
<title>HIV/AIDS Update - Kaletra (lopinavir/ritonavir) package insert revision regarding drug-drug interaction information</title>
<link>http://my-spam-email.blogspot.com/2010/01/hivaids-update-kaletra.html</link>
<description>On January 29, 2009, FDA approved revisions to the Kaletra (lopinavir/ritonavir)...</description>
<pubDate>Fri, 29 Jan 2010 15:19:15 EDT</pubDate>
<source url="http://my-spam-email.blogspot.com">My Spam Email</source>
</item>
<item>
<title>U.S. Food and Drug Administration Approves Labeling Update for PREZISTA(R) To Include 96-Week Data in HIV-1 Infected Adult Patients</title>
<link>http://www.pharmapipeline.info/2010/01/us-food-and-drug-administration.html</link>
<description>Both ARTEMIS and TITAN evaluated the efficacy and safety of PREZISTA with ritonavir (r) vs. ... lopinavir/r in combination with other antiretrovirals (ARVs) for the treatment of human immunodeficiency virus (HIV-1)...</description>
<pubDate>Fri, 29 Jan 2010 02:02:41 EDT</pubDate>
<source url="http://www.pharmapipeline.info">Pharma Pipeline News</source>
</item>
<item>
<title>U.S. Food and Drug Administration Approves Labeling Update for PREZISTA(R) To Include 96-Week Data in HIV-1 Infected …</title>
<link>http://www.diseasesandconditionsblog.info/u-s-food-and-drug-administration-approves-labeling-update-for-prezistar-to-include-96-week-data-in-hiv-1-infected/8193</link>
<description>Both ARTEMIS and TITAN evaluated the efficacy and safety of PREZISTA with ritonavir (r) vs. ... lopinavir/r in combination with other …   Read more on PR Newswire via Yahoo! Finance...</description>
<pubDate>Thu, 28 Jan 2010 21:42:36 EDT</pubDate>
<source url="http://www.diseasesandconditionsblog.info">Diseases And Conditions Blog</source>
</item>
</channel>
</rss>
